Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BCL6 |
| Upstream (Parents) |
|---|
| (<<) EPAS1 → BCL6 |
| (<<) IL11RA → BCL6 |
| (<<) C2orf67 → BCL6 |
| (<<) BTD → BCL6 |
| Downstream (Children) |
|---|
| BCL6 → C20orf117 (>>) |
| BCL6 → EPAS1 (>>) |
| BCL6 → MTRF1L (>>) |
| BCL6 → CAV3 (>>) |
| BCL6 → MAGEA9B///MAGEA9 (>>) |
| BCL6 → UBQLN3 (>>) |
| BCL6 → UHRF1BP1L (>>) |
| BCL6 → HIST1H3J (>>) |
| BCL6 → AANAT (>>) |
| BCL6 → DUX1///DUX3///DUX5 (>>) |
| BCL6 → ELK4 (>>) |
| BCL6 → CYTH1 (>>) |
| BCL6 → TK2 (>>) |
| BCL6 → RPL21P68 (>>) |
| BCL6 → CCDC57 (>>) |
| BCL6 → WDTC1 (>>) |
| BCL6 → C2orf67 (>>) |
| BCL6 → NRIP1 (>>) |
| BCL6 → RFX3 (>>) |
| BCL6 → ABCD4 (>>) |
